SCHEMBL21024879

SCHEMBL21024879

COc1cc2oc(=O)c(C(=O)Nc3ccccc3C(N)=O)cc2cc1O

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.61
RAB9A P51151 10/20 0.60
NPC1 O15118 9/20 0.60
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
CRHBP P24387 1/20 0.57
CRHR2 Q13324 1/20 0.57
MAOA P21397 1/20 0.53
MAPT P10636 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
GAA P10253 2/20 0.53
NPSR1 Q6W5P4 1/20 0.52
KDM4E B2RXH2 2/20 0.51
POLB P06746 2/20 0.51
F12 P00748 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9606855 0.92 MAOB (0.65) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL12723651 0.83 MAOB (0.61) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL20106670 0.82 RAB9A (0.70) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL16838624 0.81 MAOB (0.65) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL28563872 0.80 MAOB (0.68) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL12723220 0.77 RAB9A (0.62) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL17277766 0.76 MAOB (0.64) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL19695913 0.76 GPR35 (0.51) MAOBRAB9ANPC1KMT2AMEN1
SCHEMBL22340657 0.75 TSHR (0.75) RAB9ANPC1KMT2AMEN1SMN1; SMN2
SCHEMBL16838626 0.73 RAB9A (0.57) MAOBRAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3485883-A1 METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION OccuRx Pty Ltd (AU) 2019-05-22 EP disclosed